IP Library Patent Application 12746581
Patent Application
App. No. 12/746,581

Activated T Cells

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/746,581
Abstract

Provided are compositions comprising activated T cells and activated T cells armed with bispecific antibodies directed at cancer antigens which are poor responders to alloantigen, and methods of using the compositions to help engraftment and improve anti-tumor effects.

Claims (12)

1 . A composition comprising cord blood mononuclear cells wherein said cord blood mononuclear cells do not react to allo-antigens on other cord bloods.

2 . A composition according to claim 1 wherein said cord blood mononuclear cells include cord blood T cells and other mononuclear cell components in cord blood.

3 . A composition according to claim 2 wherein said cord blood T cells include anti-CD3 activated cord blood T and said mononuclear cell components include activated mononuclear cell components.

4 . A composition according to claim 3 wherein said anti-CD3 activated cord blood T cells and other activated mononuclear cell components in cord blood do not react to allo-antigens on human adult peripheral blood mononuclear cells as well as non-cord-blood tissues.

5 . A composition for providing helper activity to facilitate engraftment comprising cord blood T cells and/or other non-lymphoid activated cord blood cell components.

6 . A composition according to claim 5 wherein said T cells are activated T cells.

7 . A composition according to claim 5 wherein said T cells are irradiated cord blood T cells.

8 . A composition according to claim 6 wherein said T cells are irradiated cord blood T cells.

9 . A composition according to claim 5 further comprising a bispecific antibody targeted to bone marrow.

10 . A composition according to claim 9 wherein said T cells are activated cord blood T cells.

11 . A composition for facilitating engraftment comprising activated or non-activated mesenchymal stromal cells from cord blood and a bispecific antibody targeted to bone marrow.

12 . A composition according to claim 2 wherein said cord blood T cells and other mononuclear cell components in cord blood do not react to allo-antigens in adult peripheral blood on other cord bloods.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 29, 2017
From: WAYNE STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 043708/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2010
From: LUM, LAWRENCE G
To: WAYNE STATE UNIVERSITY
Reel/Frame 024986/0234 →